FrancineKaufmanMD
Pediatric Endocrinology • Los Angeles, CAPediatric Endocrinologist, Children's Hospital Los Angeles, Endocrinology
Dr. Kaufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-361-3550Fax+1 323-361-8052
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Endocrinology, 1978 - 1980- Children's Hospital Los AngelesResidency, Pediatrics, 1976 - 1978
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1976
Certifications & Licensure
CA State Medical License 1978 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2005
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 4 citationsDevice profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacyConcetta Irace, Antonio Cutruzzolà, Katherine S. Tweden, Francine R. Kaufman
Expert Review of Medical Devices. 2021-09-24 - 35 citationsEvaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.Satish K. Garg, David R. Liljenquist, Bruce W. Bode, Mark P. Christiansen, Timothy S. Bailey
Diabetes Technology & Therapeutics. 2021-09-09 - 8 citationsLongitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal CyclesKatherine S. Tweden, Dorothee Deiss, Ravi Rastogi, Suresh Addaguduru, Francine R. Kaufman
Diabetes Technology & Therapeutics. 2020-04-27
Press Mentions
- Eversense Trial Expands to Pediatric Diabetes PatientsApril 19th, 2023
- Senseonics Announces First Paediatric Insertion for Eversense in TrialApril 19th, 2023
- Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical TrialApril 18th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
